Machina Capital S.A.S. decreased its stake in Albemarle Corporation (NYSE:ALB – Free Report) by 74.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,183 shares of the specialty chemicals company’s stock after selling 9,159 shares during the period. Machina Capital S.A.S.’s holdings in Albemarle were worth $337,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Primecap Management Co. CA acquired a new position in Albemarle during the second quarter valued at approximately $358,101,000. Deutsche Bank AG acquired a new stake in shares of Albemarle in the 2nd quarter valued at approximately $131,049,000. Bank of New York Mellon Corp acquired a new stake in shares of Albemarle in the 2nd quarter valued at approximately $103,268,000. Robeco Institutional Asset Management B.V. grew its stake in shares of Albemarle by 2,981.1% in the third quarter. Robeco Institutional Asset Management B.V. now owns 733,793 shares of the specialty chemicals company’s stock valued at $77,621,000 after buying an additional 709,977 shares in the last quarter. Finally, ProShare Advisors LLC grew its stake in shares of Albemarle by 69.7% in the third quarter. ProShare Advisors LLC now owns 1,436,117 shares of the specialty chemicals company’s stock valued at $151,912,000 after buying an additional 589,787 shares in the last quarter. Institutional investors and hedge funds own 92.87% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on ALB shares. Royal Bank Of Canada lowered their target price on shares of Albemarle from $129.00 to $119.00 and set an “outperform” rating on the stock in a report on Friday, November 6th. Citigroup increased their price target on shares of Albemarle from $125.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, November 9th. Wall Street Zen downgraded shares of Albemarle from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. HSBC decreased their price objective on shares of Albemarle from $230.00 to $170.00 and set a “buy” rating for the company in a research report on Thursday, July 23rd. Finally, UBS Group lowered their price objective on shares of Albemarle from $150.00 to $137.00 and set a “buy” rating on the stock in a research note on Monday, November 9th. Fifteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $152.63.
View Our Latest Stock Analysis on Albemarle
Albemarle Stock Performance
Albemarle stock traded down $1.23 during mid-day trading on Friday, hitting $93.62. 1,177,544 shares of the company’s stock traded hands, compared to its average volume of 2,510,124. The firm has a 50 day simple moving average of $103.61 and a two-hundred day simple moving average of $145.56. Albemarle Corporation has a fifty-two week low of $89.77 and a fifty-two week high of $221.00. The stock has a market cap of $11.05 billion, a price-to-earnings ratio of 22.61, a P/E/G ratio of 0.59 and a beta of 1.34. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.34 and a quick ratio of 1.57.
Albemarle (NYSE:ALB – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The specialty chemicals company reported $2.58 EPS for the quarter, beating the consensus estimate of $2.53 by $0.05. The firm had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.52 billion. Albemarle had a net margin of 10.40% and a return on equity of 14.91%. The company’s quarterly revenue was up 18.8% on a year-over-year basis. During the same period in the previous year, the company earned ($0.19) earnings per share. On average, research analysts expect that Albemarle Corporation will post 10.64 EPS for the current fiscal year.
Albemarle Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, December 18th will be issued a dividend of $0.41 per share. The ex-dividend date of this dividend is Friday, December 18th. This represents a $1.64 annualized dividend and a dividend yield of 1.8%. Albemarle’s payout ratio is presently 39.61%.
Albemarle Profile
Albemarle Corporation is a specialty chemicals company that produces lithium, bromine and refining catalysts. Its products serve industries including energy storage, transportation, electronics, petroleum refining and pharmaceuticals. The company supplies lithium compounds used in rechargeable batteries and other applications. It also makes bromine-based products for uses such as flame retardants and water treatment, along with catalysts used in refining petroleum. Albemarle traces its history to 1887 and is headquartered in Charlotte, North Carolina.
Recommended Stories
- Five stocks we like better than Albemarle
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Corporation (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
